GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending ...

The incidence and risk for suicidality and self-harm were low for individuals given glucagon-like peptide-1 receptor agonists ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the ...

Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...

DaVita has dug a narrow moat in dialysis services, operating about 35% of all dialysis clinics in the United States and some clinics globally. We believe the company’s competitive advantages in this ...

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

Discover science-backed methods to address sagging skin, including home remedies and clinical treatment for those ...

Eli Lilly and Company (NYSE:LLY) is a leading multinational pharmaceutical company that develops and markets healthcare products across various therapeutic areas. Its products range from ...

Among patients with diabetes receiving PCI, novel antidiabetic agents, compared with standard treatment, may reduce risk for acute kidney injury.

HealthDay News — Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to a study published online March ...

Continuing GLP-1 RA use through surgery increases risk for surgical complications including aspiration and conversion to intubation ...

“Ozempic face” refers to the sagging of skin due to rapid weight loss. Experts say it’s preventable by slowing down weight ...